{"name":"Sparian Biosciences, Inc","slug":"sparian-biosciences-inc","ticker":"","exchange":"","domain":"sparian.com","description":"Sparian Biosciences, Inc is a biotechnology company focused on developing innovative therapies for patients with significant unmet medical needs. The company currently has two drug candidates in Phase 1 clinical trials, SBS-147 and SBS-1000, both of which are designed to address critical therapeutic areas.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNNVNpOEo5Q2tVdHZiREdlNjd4R1FkZkhpM2ZXUnJvNmRwYzIzanp3a3l4WU9iTjduaE5nVjBiYm4ycTZXVFlZNTNIVU1BVTYtbDhwbVVMSjlDQWFMeFRva3Bvd1VTcEJUd1JqZkVMUG9DazFOZGRXMnhBT08zU0s5Y2J1VHgxcTY0S1dQSndDN0ZMZDg0UThROGFuQUcyNHd2cDJ0RlB1anlTQnU5Sm1LaWJ2U0phZ2c?oc=5","date":"2024-11-15","type":"pipeline","source":"BioWorld News","summary":"NIDA grant supports Sparian’s SBS-226 for opiate use disorder and withdrawal - BioWorld News","headline":"NIDA grant supports Sparian’s SBS-226 for opiate use disorder and withdrawal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOR291SnV0OE1OQmt4VnVnVlNpWVNrRzNkMGQ0UTZIRVBHOTVqeTYzbDBzbUxEcWJQTkw0MmdjNTIwZkxDcllhNUh3ZnplbnBQT0FKV1NkamZqSVQ2VjBfSnN3V0hUZzdMVWRBSDMzVTdOZER0d0dtVWk4QWg2VlN2SHQyVWhYaTlPWGE1SEN5YlZ2SjFRR3lrTGRrdW9xdGNwbldFMEstZlZOUQ?oc=5","date":"2023-09-18","type":"pipeline","source":"UF Health - University of Florida Health","summary":"UF Health researchers to develop novel treatment for stimulant use disorder - UF Health - University of Florida Health","headline":"UF Health researchers to develop novel treatment for stimulant use disorder - UF Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQeWdibEhmaUVFUUJrYV9IVFRSbjRUVmh3R2JaTGsySE5HN1RoWV8zY2YwUTJORWtEdWkxOW9EZ3NBRzBodDRVVng4UEtyNk9FMmNGNVZSbFUwaktjX1JFTE1SZFFtRjhxbmh1UWswaUFjVmRMMmVDelIwdklfY0JySzBsVXl0ZUpUUTlRWHFGal9QUWtEQVUtZGNiQVdCTEV4T3FDVS1FcFRtbXJvRGYxUVQwenBUZw?oc=5","date":"2019-12-17","type":"pipeline","source":"Fierce Healthcare","summary":"NYU Langone opens NYC's largest biotech incubator with backing from biopharma giants - Fierce Healthcare","headline":"NYU Langone opens NYC's largest biotech incubator with backing from biopharma giants","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}